Second Heart Assist, Inc.

Second Heart Assist, Inc. has developed both a catheter-based circulatory assist pump and a wireless power chronic implant aortic stent pump to aid patients with heart failure and reverse cardio-renal dysfunction. The company completed the first in-human study and is moving now to longer-duration use studies. Second Heart Assist objectives are to improve the quality of life by reducing the heart’s work-load and improve perfusion. The enhancement of renal function reduces risks associated with toxic contrasts used in percutaneous catheterization interventions (High Risk PCI). Additionally, the product helps patients recover from cardiogenic shock and get acute decompensating heart failure patients back to normal hemodynamics.